CIM
RDY icon

Confluence Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Confluence Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
17,910
+2,414
+16% +$32.6K ﹤0.01% 271
2026
Q1 		$215K Buy
15,496
+736
+5% +$10.2K ﹤0.01% 268
2025
Q4 		$207K Hold
14,760
– – ﹤0.01% 288
2025
Q3 		$206K Sell
14,760
-625
-4% -$8.99K ﹤0.01% 283
2025
Q2 		$231K Sell
15,385
-1,250
-8% -$17.9K ﹤0.01% 269
2025
Q1 		$219K Sell
16,635
-1,655
-9% -$22.8K ﹤0.01% 278
2024
Q4 		$289K Hold
18,290
– – ﹤0.01% 273
2024
Q3 		$291K Buy
18,290
+60
+0.3% +$966 ﹤0.01% 277
2024
Q2 		$278K Sell
18,230
-420
-2% -$6.02K ﹤0.01% 274
2024
Q1 		$274K Sell
18,650
-25
-0.1% -$365 ﹤0.01% 278
2023
Q4 		$260K Hold
18,675
– – ﹤0.01% 279
2023
Q3 		$250K Sell
18,675
-2,720
-13% -$36.8K ﹤0.01% 269
2023
Q2 		$270K Hold
21,395
– – ﹤0.01% 274
2023
Q1 		$244K Hold
21,395
– – ﹤0.01% 283
2022
Q4 		$221K Buy
21,395
+235
+1% +$2.54K ﹤0.01% 300
2022
Q3 		$222K Hold
21,160
– – ﹤0.01% 286
2022
Q2 		$234K Sell
21,160
-220
-1% -$2.39K ﹤0.01% 294
2022
Q1 		$238K Sell
21,380
-3,210
-13% -$36.4K ﹤0.01% 297
2021
Q4 		$322K Sell
24,590
-1,165
-5% -$14.7K ﹤0.01% 258
2021
Q3 		$336K Buy
25,755
+200
+0.8% +$2.67K ﹤0.01% 258
2021
Q2 		$376K Sell
25,555
-1,130
-4% -$15.8K 0.01% 249
2021
Q1 		$328K Buy
26,685
+310
+1% +$3.98K ﹤0.01% 258
2020
Q4 		$376K Sell
26,375
-580
-2% -$7.81K 0.01% 250
2020
Q3 		$375K Sell
26,955
-425
-2% -$5.07K 0.01% 245
2020
Q2 		$290K Buy
+27,380
New +$279K ﹤0.01% 259

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Confluence Investment Management's RDY Position: Q2 2026 in Review

Confluence Investment Management increased its Dr. Reddy's Laboratories (RDY) stake by 16% in Q2 2026, buying an estimated $32.6K and bringing the position to 17,910 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #271.

Confluence Investment Management first reported a position in RDY in Q2 2020 and has held it in 25 quarters since. The position peaked at $376K in Q2 2021. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Confluence Investment Management held 17,910 shares of Dr. Reddy's Laboratories worth $260K as of Q2 2026.
  • Confluence Investment Management bought 2,414 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $32.6K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Confluence Investment Management's portfolio in Q2 2026, its #271 holding.
  • Confluence Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2020 and has held it in 25 quarters since.
  • Confluence Investment Management's Dr. Reddy's Laboratories position peaked at $376K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Confluence Investment Management's 13F filing for Q2 2026, filed 1 Jul 2026.